Does anything please you? This long covid thing is a small, partnered early blood study at minimal cost and minimal involvement for ANP. There's really no significant "focus, energy, resources" being placed on this. I bet you were begging for ANP to release new indications too. Well, this is one potential new indication. Either you want new indications for ATL1102 or you don't. Well this is one possible one, and it is coming at minimal involvement and cost for ANP. Sheesh.
Ann: Poster Presentation at 2022 MDA Conference, page-48
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |